BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11289346)

  • 1. Clinical picture: nail changes secondary to docetaxel.
    Wasner G; Hilpert F; Baron R; Pfisterer J
    Lancet; 2001 Mar; 357(9260):910. PubMed ID: 11289346
    [No Abstract]   [Full Text] [Related]  

  • 2. Nail changes secondary to docetaxel (Taxotere).
    Correia O; Azevedo C; Pinto Ferreira E; Braga Cruz F; Polónia J
    Dermatology; 1999; 198(3):288-90. PubMed ID: 10393455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Yellow nails].
    Auvinet M; Dahan S; Dingremont C; Ollier S; Juchet H; Arlet P
    Rev Med Interne; 1998 May; 19(5):353-4. PubMed ID: 9775172
    [No Abstract]   [Full Text] [Related]  

  • 4. Docetaxel chemotherapy induces transverse superficial loss of the nail plate.
    Llombart-Cussac A; Pivot X; Spielmann M
    Arch Dermatol; 1997 Nov; 133(11):1466-7. PubMed ID: 9371043
    [No Abstract]   [Full Text] [Related]  

  • 5. Nail changes due to docetaxel.
    Pavithran K; Doval DC
    Br J Dermatol; 2002 Apr; 146(4):709-10. PubMed ID: 11966714
    [No Abstract]   [Full Text] [Related]  

  • 6. Nail bed dyschromia secondary to docetaxel therapy.
    Jacob CI; Patten SF
    Arch Dermatol; 1998 Sep; 134(9):1167-8. PubMed ID: 9762045
    [No Abstract]   [Full Text] [Related]  

  • 7. Docetaxel-induced subungual hemorrhage.
    Vanhooteghem O; André J; Vindevoghel A; Vandenbossche L; Vandeveire A; Song M
    Dermatology; 1997; 194(4):419-20. PubMed ID: 9252781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onycholysis in patients treated with docetaxel.
    Obermair A; Binder M; Barrada M; Bancher-Todesca D; Asseryanis E; Kubista E
    Ann Oncol; 1998 Feb; 9(2):230-1. PubMed ID: 9553674
    [No Abstract]   [Full Text] [Related]  

  • 9. Subungual abscess: a new ungual side-effect related to docetaxel therapy.
    Vanhooteghem O; Richert B; Vindevoghel A; Vandenbossche L; Vandeveire A; de la Brassinne M
    Br J Dermatol; 2000 Aug; 143(2):462-4. PubMed ID: 10951175
    [No Abstract]   [Full Text] [Related]  

  • 10. Taxane-induced nail changes: incidence, clinical presentation and outcome.
    Minisini AM; Tosti A; Sobrero AF; Mansutti M; Piraccini BM; Sacco C; Puglisi F
    Ann Oncol; 2003 Feb; 14(2):333-7. PubMed ID: 12562663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel-related skin, nail, and vascular toxicity.
    Leonard GD; Zujewski JA
    Ann Pharmacother; 2003 Jan; 37(1):148. PubMed ID: 12564432
    [No Abstract]   [Full Text] [Related]  

  • 12. Nail toxicity related to taxanes.
    Mourad YA; Matta-Muallem M; Shamseddine A
    Dermatol Online J; 2003 Aug; 9(3):15. PubMed ID: 12952762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel-induced nail dystrophy.
    Nicolopoulos J; Howard A
    Australas J Dermatol; 2002 Nov; 43(4):293-6. PubMed ID: 12423438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nail alterations secondary to pactitaxel [corrected] therapy.
    Almagro M; Pozo JD; Garcia J; Vasquez A; Fonseca E
    Eur J Dermatol; 2000 Mar; 10(2):146-7. PubMed ID: 10694317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Taxane-induced ungual anomalies].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2000 Jan; 127(1):130. PubMed ID: 10717580
    [No Abstract]   [Full Text] [Related]  

  • 16. Ataxia following docetaxel infusion.
    Hofstra LS; van der Graaf WT; de Vries EG; Haaxma-Reiche H; Willemse PH
    Ann Oncol; 1997 Aug; 8(8):812-3. PubMed ID: 9332695
    [No Abstract]   [Full Text] [Related]  

  • 17. [Onycholysis due to docetaxel in breast cancer treatment].
    Grasland A; Grandjean M; Rist S; Bosquet A; Vinceneux P
    Rev Med Interne; 2005 May; 26(5):427-8. PubMed ID: 15893036
    [No Abstract]   [Full Text] [Related]  

  • 18. Docetaxel induced cardiotoxicity.
    Shimoyama M; Murata Y; Sumi KI; Hamazoe R; Komuro I
    Heart; 2001 Aug; 86(2):219. PubMed ID: 11454849
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe syndrome of inappropriate antidiuretic hormone secretion with docetaxel treatment in metastatic breast cancer.
    Langer-Nitsche C; Lück HJ; Heilmann M
    Acta Oncol; 2000; 39(8):1001. PubMed ID: 11206991
    [No Abstract]   [Full Text] [Related]  

  • 20. Exudative hyponychial dermatitis associated with capecitabine and docetaxel combination chemotherapy for metastatic breast carcinoma: report of three cases.
    Chen GY; Chang TW; Chen WC
    Br J Dermatol; 2003 May; 148(5):1071-3. PubMed ID: 12786853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.